A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
Many cancer patients do not respond to chemotherapies because the drugs never reach the cancer cells. Even in nanomedicine, which is one of the best new methods for delivering drugs to a tumor, only about one percent of a dose of nanoparticles will successfully arrive at the intended tumor site, while the rest are filtered out by the immune cells of the liver and spleen.
Using chloroquine, the researchers not only increased the circulation of nanoparticles in the body, but also reduced the body’s filtration of nanoparticles, as well as improved drug delivery to breast tumors. The study was recently published in Scientific Reports, a research journal from the Nature Publishing Group.
Led by Mauro Ferrari, Ph.D., president and CEO of the Houston Methodist Research Institute, and Joy Wolfram, Ph.D. (now at Mayo Clinic’s campus in Jacksonville, Florida), the research showed that chloroquine interfered with immune cells called macrophages, which are used by the body to identify microscopic foreign objects and destroy them.
In this study, mice models received injections of chloroquine, followed by an injection of nanoparticles. Chloroquine decreased the macrophages’ ability to clean up the nanoparticles. The findings are significant, because the nanoparticles not only remained in circulation, but also accumulated in mouse tumors, as well as in the lungs of healthy mice, suggesting that the approach also may enhance treatment for lung diseases.
Chloroquine was invented in the 1940s for the prevention and treatment of malaria. Since it mildly suppresses the immune system, the drug also is used in some autoimmune disorders, such as rheumatoid arthritis and lupus. Apart from this research, the drug is also being studied in other cancers, such as triple-negative breast cancer and pancreatic cancer.
Ferrari, considered one of the founders of nanomedicine and transport oncophysics (the physics of mass transport within a cancer lesion), says researchers and clinicians need to understand the limitations of transport mechanisms to identify effective immunotherapy treatments for patients.
The Latest on: Drug delivery
- 24 Cities Sue State Over Regulations, Trying To Put An End To Pot Delivery on April 17, 2019 at 7:05 pm
The Bureau of Cannabis Control developed delivery regulation over a two-year period. READ ALSO: DEA Warns Of New Drug 100 Times More Potent Than Fentanyl “Everything is regulated to a ‘T.&rsquo […]
- Shape-Shifting Biomaterials Form the Basis of New Drug Delivery Platforms (1 of 1) (image) on April 17, 2019 at 1:12 pm
An x-ray image showing the flower-like device deployed in the esophagus in pigs, where it could deliver molecules through degradable microneedles. This material relates to a paper that appeared in the ... […]
- Temperature-Triggerable Gastrointestinal (GI) Drug Delivery Devices (image) on April 17, 2019 at 11:20 am
Investigators tested two prototype devices in a porcine model: 1) a temperature-triggerable flower-like system for esophageal drug delivery and 2) a temperature-triggerable flexible mechanical ... […]
- Drug Delivery in Cancer Market 2019 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2024 on April 17, 2019 at 4:00 am
WiseGuyReports.com adds “Drug Delivery in Cancer Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database. This ... […]
- Global Drug Delivery in Cancer Industry Analysis 2019, Market Growth, Trends, Opportunities Forecast To 2024 on April 17, 2019 at 3:56 am
WiseGuyReports.com adds “Drug Delivery in Cancer Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database. This report focuses on the ... […]
- New drug-delivery system senses high oxidant levels, responds to body chemistry and environment on April 16, 2019 at 10:32 pm
Oxidants found within living organisms are byproducts of metabolism and are essential to wound-healing and immunity. However, when their concentrations become too high, inflammation and tissue damage ... […]
- Drug Delivery Technology Market 2016 Industry Overview, Growth Analysis, Regional Demand and Growth Till 2026: Future Market Insights on April 16, 2019 at 8:25 pm
Valley Cottage, NY -- (SBWIRE) -- 04/16/2019 -- Drug delivery system is the process of administering therapeutic substance through common route of administration to achieve a therapeutic effect in ... […]
- eBrain: a Three Dimensional Simulation Tool to Study Drug Delivery in the Brain on April 16, 2019 at 2:17 am
Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease are severe disorders with acute symptoms that gradually progress. In the course of developing disease-modifying treatments for ... […]
- New method may lead to better in vivo drug delivery on April 12, 2019 at 4:00 am
At some point, every person is likely to experience an inflammatory condition. There are many causes of inflammation, and just as many treatments. Some types of inflammation disappear by ... […]
- Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression on April 10, 2019 at 6:50 am
Parkinson's disease affects between 7 and 10 million people worldwide and the number of people diagnosed is soaring due to the ageing population. It affects dopamine-producing nerve cells in the brain ... […]
via Google News and Bing News